Philpott, Carl http://orcid.org/0000-0002-1125-3236
,
le Conte, Steffi
Beard, David
Cook, Jonathan
Sones, William
Morris, Steve
Clarke, Caroline S.
Thomas, Mike
Little, Paul
Vennik, Jane
Lund, Valerie
Blackshaw, Helen
Schilder, Anne
Durham, Stephen
Denaxas, Spiros
Carpenter, James
Boardman, James
Hopkins, Claire
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-0614-20011)
Article History
Received: 27 November 2018
Accepted: 21 March 2019
First Online: 29 April 2019
Ethics approval and consent to participate
: Version 3.0 of the protocol (dated 31 August 2018) was approved centrally by the research ethics committee of North East – Newcastle & North Tyneside 2 on 20 September 2018. The MHRA gave approval for a clinical trial on 13 July 2018. The trial manager has given details to the Health Regulation Authority of each of the sites that will be included in the trial. Local site research and development departments will confirm their capacity and capability and the Oxford SITU will issue a green light to proceed before recruitment at each site can commence. Informed consent will be obtained from all study participants as detailed above.
: Not applicable. This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (PGfAR) Programme (Grant Reference Number RP-PG-0614-20011). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.